Access to Medicines for Non-Communicable Diseases (NCDS) during COVID-19 in Kenya: A Descriptive Commentary
Evidence shows that those with non-communicable diseases (NCDs) are at higher risk for serious illness and mortality from COVID-19. In Kenya, about 50% of the COVID-19 patients who have died had an NCD. We sought to describe the challenges faced in accessing NCD medicines in Kenya during the pandemi...
Saved in:
Main Authors: | Zana Wangari Kiragu (Author), Gladwell Gathecha (Author), Martin K. Mwangi (Author), Zachary Ndegwa (Author), Sonak Pastakia (Author), Daniel Nyagah (Author), Richard N. Cizungu (Author), Mariana Takah Mutwiri (Author), Meshack Ndolo (Author), Veronika J. Wirtz (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors associated with late diagnosis of cervical cancer at two national referral hospitals, Kenya 2017: A case control study
by: Valerian Mwenda, et al.
Published: (2024) -
Demographic profile and pattern of fatal injuries in Nairobi, Kenya, January-June 2014
by: Gladwell Koku Gathecha, et al.
Published: (2017) -
Coping with access barriers to non‐communicable disease medicines: qualitative patient interviews in eight counties in Kenya
by: Gloria Ng, et al.
Published: (2021) -
Burden of NCDs, Policies and Programme for Prevention and Control of NCDs in India
by: R K Srivastava, et al.
Published: (2011) -
Renaming the NCDs
by: Arjuna Aluwihare
Published: (2002)